Cytori Therapeutics reported $-4116000 in Net Income for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Baxter International BAX:US $ 71M 167M
Cerus CERS:US $ -12.28M 3.16M
Cytori Therapeutics CYTX:US $ -4.12M 0.04M
Dr.Reddys Laboratories DRRD:IN IR 970M 6123M
Genocea Biosciences GNCA:US $ -15.98M 2.7M
Haemonetics HAE:US $ 9.74M 13.49M
Infinity Pharmaceuticals INFI:US $ -12.44M 0.78M
Merrimack Pharmaceuticals MACK:US $ -132000 343K
Mirati Therapeutics MRTX:US $ -188.39M 11.23M
Northwest Biotherapeutics NWBO:US -14214000 147.53M
Starpharma Holdings Ltd SPL:AU -8449000 853K
Sun Pharmaceuticals SUNP:IN IR -22772.5M 43360.5M
Teva Pharmaceutical TEVA:IT -955000000 797M